Cancer Immunology – Products

Trial could generate future alternative treatment for metastatic melanoma.

PharmaNet collaborate with CITN to help identify trials with immunotherapy agents prioritized by the CITN as having high potential for cancer therapy.

Network consists of 27 institutions with the goal of making effective immunotherapy agents broadly available for treatment of cancer.

U.S. patent and trademark office has issued an official notice of allowance for a new U.S. patent specific to the DPX-0907 therapeutic cancer vaccine.

HydroFlex microplate washer has allowed hematologists at University of Modena and Reggio Emilia, Italy, to introduce automated washing for ELISpot assays.

Utilsing Tecan’s HydroFlex microplate washer hematologists at the Department of Oncology and Hematology, University of Modena and Reggio Emilia, Italy, to introduce automated washing for Enzyme-Linked ImmunoSpot assays.

This week AnaSpec has introduced 50 new catalog peptides and one new fluorescent dye.

AutovaxID-C reduces the possibility of cross contamination and allows segregation of patient specific vaccine batches.